AmmarAlzoubiMD

Oncology • Newark, DE

Physician

Join to view full profile

Are you Dr. Alzoubi?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
4701 Ogletown Stanton Rd
Ste 2300
Newark, DE 19713

Summary

Dr. Ammar Alzoubi, MD is an oncologist in Newark, Delaware. He is currently licensed to practice medicine in Delaware, New York, and Minnesota. He is affiliated with ChristianaCare and Christiana Care - Wilmington Hospital.

Education & Training

UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 1998 - 2001
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1995 - 1998
University of Aleppo Faculty of MedicineClass of 1988

Certifications & Licensure

DE State Medical License 2022 - 2025
MN State Medical License 2012 - 2023
ND State Medical License 2012 - 2023
NY State Medical License 2018 - 2023
MI State Medical License 2005 - 2015
MA State Medical License 1999 - 2006
WI State Medical License 1997 - 2001
OH State Medical License 1997 - 1998
American Board of Internal Medicine Hematology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

56 citations
NF1 Inactivation in Adult Acute Myelogenous Leukemia
Brian Parkin, Peter Ouillette, Yin Wang, Yan Liu, Whitney Wright
Clinical Cancer Research. 2010-08-15
342 citations
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma
Andrzej Jakubowiak, Dominik Dytfeld, Kent A. Griffith, Daniel Lebovic, David H. Vesole
Blood. 2012-08-30
64 citations
Phase II Trial of Combination Therapy With Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Myeloma
Andrzej Jakubowiak, Tara Kendall, Ammar Al-Zoubi, Yasser Khaled, Shin Mineishi
Journal of Clinical Oncology. 2009-10-20

Press Mentions

Sanford Health Completes North Dakota's First Bone Marrow TransplantNovember 17th, 2021